1921
Volume 90, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Although ivermectin treatment can induce serious adverse events (SAEs) in individuals harboring high microfilaremia (mf), not all patients with high mf levels develop such reactions, suggesting that cofactors may be involved. A study was conducted in Cameroon to investigate the possible role of coinfection at the time of ivermectin treatment in the development of SAEs. Before their first ivermectin treatment, thick smears were obtained from 4,175 individuals to determine the burden of sp., , and . After treatment, 18 (4.3 per 1,000) patients developed a non-neurologic SAE. Logistic regression analysis, adjusting for age, sex, infection, and infection intensities, confirmed that mf was the main risk factor for SAEs. We found no evidence that coinfection with at the time of ivermectin treatment was associated with the occurrence of -related SAEs in this population.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0189
2014-02-05
2017-09-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/90/2/335.html?itemId=/content/journals/10.4269/ajtmh.13-0189&mimeType=html&fmt=ahah

References

  1. Zouré HGM, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH, Remme JHF, , 2011. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the rapid assessment procedure for loiasis (RAPLOA). PLoS Negl Trop Dis 5: e1210.[Crossref]
  2. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux J-P, , 2003. Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2 (Suppl 1): S4.[Crossref]
  3. Gardon J, Gardon-Wendel N, Demanga-Ngangue Kamgno J, Chippaux JP, Boussinesq M, , 1997. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350: 1822.[Crossref]
  4. Kamgno J, Pion SD, Mackenzie CD, Thylefors B, Boussinesq M, , 2009. Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events. Am J Trop Med Hyg 81: 10561061.[Crossref]
  5. Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG, , 2010. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg 83: 2832.[Crossref]
  6. White V, Lewallen S, Beare N, Molyneux M, Taylor T, , 2009. Retinal pathology of pediatric cerebral malaria in Malawi. PLoS One 4: e4317.[Crossref]
  7. Kamgno J, Boussinesq M, Labrousse F, Nkegoum B, Thylefors BI, Mackenzie CD, , 2008. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp. Am J Trop Med Hyg 78: 546551.
  8. Twum-Danso NAY, , 2003. Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria J 2 (Suppl 1): S3.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0189
Loading
/content/journals/10.4269/ajtmh.13-0189
Loading

Data & Media loading...

  • Received : 10 Apr 2013
  • Accepted : 23 Aug 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error